ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve
Safety and Effectiveness of Balloon-Expandable Bioprosthetic SAPIEN X4 Transcatheter Heart Valve
Sponsor: Edwards Lifesciences
This NA trial investigates Aortic Stenosis, Severe and is currently ongoing. Edwards Lifesciences leads this study, which shows 18 recorded versions since 2022 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
18 versions recorded-
Sep 2025 — Present [monthly]
Active Not Recruiting NA
-
Jan 2025 — Sep 2025 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Jan 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
May 2024 — Jul 2024 [monthly]
Recruiting NA
▶ Show 13 earlier versions
-
Feb 2024 — May 2024 [monthly]
Recruiting NA
-
Jan 2024 — Feb 2024 [monthly]
Recruiting NA
-
Dec 2023 — Jan 2024 [monthly]
Recruiting NA
-
Nov 2023 — Dec 2023 [monthly]
Recruiting NA
-
Oct 2023 — Nov 2023 [monthly]
Recruiting NA
-
Sep 2023 — Oct 2023 [monthly]
Recruiting NA
-
Aug 2023 — Sep 2023 [monthly]
Recruiting NA
-
Jul 2023 — Aug 2023 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
-
Jan 2023 — Jul 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Dec 2022 — Jan 2023 [monthly]
Recruiting NA
-
Sep 2022 — Dec 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jul 2022 — Sep 2022 [monthly]
Not Yet Recruiting NA
Status: Withheld → Not Yet Recruiting · Phase: None → NA
-
Jan 2022 — Jul 2022 [monthly]
Withheld
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Edwards Lifesciences
For direct contact, visit the study record on ClinicalTrials.gov .